iShares iBoxx $ High Yield Corporate Bond ETF vs Rocket Lab USA Inc — how do they compare? iShares iBoxx $ High Yield Corporate Bond ETF trades at $77.23 (market cap $17.89B), while Rocket Lab USA Inc trades at $68.21 (market cap $43.74B). The key difference: Rocket Lab USA Inc is far larger — about 2.4× iShares iBoxx $ High Yield Corporate Bond ETF's market cap, and Rocket Lab USA Inc is trading nearer its 52-week high, iShares iBoxx $ High Yield Corporate Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares iBoxx $ High Yield Corporate Bond ETF for 60 Days and Rocket Lab USA Inc for 29 Days on average.
| HYG | RKLB | |
|---|---|---|
Market Cap | $17.89B | $43.74B |
Volume | 44,866,592 | 22,892,581 |
Sector | Fixed Income | Industrials |
52-Week High | $81.28 | $150.23 |
52-Week Low | $76.90 | $39.48 |
Typical Hold Time | 60 Days | 29 Days |
Enterprise Value | — | $41.57B |
Signals from Pluang's Aura AI — not financial advice
HYG trades at $77.23 with minimal daily movement (+0.06%), showing stability amid broader market volatility. The technical picture remains bearish with moving averages signaling continued downward pressure, though oscillators suggest potential stabilization. Recent dividend payments provide consistent income, with the latest $0.38 distribution paid in August 2026. The fund faces headwinds from rising Treasury yields and bond market volatility, with key technical indicators showing mixed signals between short-term stabilization and longer-term bearish momentum.
High yield bond ETFs like HYG face pressure from rising interest rates and inflation concerns, though the fund's diversified corporate bond portfolio offers yield advantages over Treasury securities. The current environment presents both income opportunities through attractive yields and risks from potential credit deterioration if economic conditions worsen. Investors should weigh the fund's income generation against interest rate sensitivity and credit risk exposure in the current tightening cycle.
Rocket Lab (RKLB) trades at $68.21, down 5.16% today, amid a bearish technical signal despite recent positive business developments. The company secured its largest-ever commercial Electron deal with Synspective for 20 launches, boosting its backlog past 100 missions. However, financials show negative profitability with a net income margin of -21.51% and elevated valuation ratios including P/S of 51.96. Technical indicators show bearish momentum with key support at $64.
The outlook remains mixed with strong analyst bullishness (76% buy ratings, $107 consensus target) contrasting with fundamental challenges. Investment opportunity lies in execution of the growing launch backlog and Neutron rocket development, while risks include sustained losses, SpaceX competition, and high valuation multiples requiring significant future growth to justify.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
HYG is the world's largest high-yield bond ETF, tracking the Markit iBoxx USD Liquid High Yield Index. It provides liquid exposure to non-investment grade corporate debt, with 2026 top holdings including Cloud Software Group and Medline.
Read more on HYG →Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →